Dermaklinika - Company finances
|
EUR
|
2019
From: 2019-10-18
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|
|
Financial data
|
|||||||
| Sales revenue | 2,871 | 33,833 | 55,767 | 92,243 | 150,411 | 186,115 | 171,871 |
| Profit before tax | -1,591 | -11,455 | 3,792 | 10,087 | 44,580 | 55,966 | -25,383 |
| Net profit | -1,591 | -11,455 | 3,792 | 10,033 | 42,346 | 53,112 | -25,383 |
| Equity | 909 | -10,546 | -6,754 | 3,278 | 45,625 | 68,738 | 23,354 |
| Liabilities | 15,131 | 32,792 | 25,154 | 11,467 | 6,566 | 48,949 | 73,928 |
| Non-current assets | 0 | 15,420 | 12,582 | 6,916 | 1,250 | 61,692 | 80,789 |
| Current assets | 16,040 | 6,826 | 5,818 | 7,829 | 50,941 | 55,995 | 16,493 |
| Total assets | 16,040 | 22,246 | 18,400 | 14,745 | 52,191 | 117,687 | 97,282 |
|
Taxes paid
|
|||||||
| STI taxes | - | - | - | - | 14,523 | 21,751 | 23,953 |
|
Financial indicators
|
|||||||
| Revenue change y/y | - | +1078.4% | +64.8% | +65.4% | +63.1% | +23.7% | -7.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -9.9% | -51.5% | 20.6% | 68.0% | 81.1% | 45.1% | -26.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -175.0% | - | - | 306.1% | 92.8% | 77.3% | -108.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -55.4% | -33.9% | 6.8% | 10.9% | 28.2% | 28.5% | -14.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -55.4% | -33.9% | 6.8% | 10.9% | 29.6% | 30.1% | -14.8% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 16.6 | - | - | 3.5 | 0.1 | 0.7 | 3.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 1,436 | 16,917 | 27,884 | 46,122 | 75,206 | 93,058 | 85,936 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Dermaklinika - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-08-23 | 2026-08-23 | 232.79 |
| 2026-08-19 | 2026-08-19 | 232.79 |
| 2024-10-24 | 2024-10-29 | 0.09 |
| 2024-07-16 | 2024-07-17 | 620.08 |
| 2022-11-21 | 2022-11-22 | 161.75 |
| 2022-11-17 | 2022-11-18 | 161.75 |
| 2022-10-28 | 2022-11-02 | 80.92 |
| 2022-10-18 | 2022-10-27 | 80.83 |
| 2022-09-16 | 2022-09-19 | 57.74 |
Dermaklinika - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-01-05 | 2026-01-05 | 225.74 |
| 2025-12-03 | 2025-12-03 | 249.71 |
| 2025-12-02 | 2025-12-02 | 249.35 |
| 2025-10-04 | 2025-10-04 | 249.71 |
| 2025-07-30 | 2025-07-30 | 8.63 |
| 2025-07-29 | 2025-07-29 | 1187.2 |
| 2025-06-04 | 2025-06-05 | 2196.5 |
| 2025-06-02 | 2025-06-03 | 2219.87 |
| 2025-06-01 | 2025-06-01 | 2197.75 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Dermaklinika, UAB (code 305290959) is a Private Limited Liability Company engaged in Medical specialists activities. In 2025, the company generated revenue of €171.9K, down 7.7% year on year, after reaching €186.1K in 2024 and €150.4K in 2023. Profitability weakened sharply: net profit was €53.1K in 2024, compared with €42.3K in 2023, before turning to a net loss of €25.4K in 2025. The 2025 profit margin was -14.8%, versus positive margins of 28.5% in 2024 and 28.2% in 2023. The balance sheet also became more leveraged in 2025, with total assets of €97.3K, equity of €23.4K and liabilities of €73.9K. Long-term assets increased to €80.8K, while short-term assets were €16.5K. Key ratios for 2025 show an equity ratio of 24.0%, debt-to-equity of 3.17 and asset turnover of 1.77x. Revenue per employee was €85.9K, while profit per employee was -€12.7K.